Relevant bibliographies by topics / Neurofibromatosis 1 And 2

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Neurofibromatosis 1 And 2'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Neurofibromatosis 1 And 2.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Neurofibromatosis 1 And 2"

1

Batista, Pollyanna Barros, Eny Maria Goloni Bertollo, Danielle de Souza Costa, et al. "Neurofibromatosis: part 2 – clinical management." Arquivos de Neuro-Psiquiatria 73, no. 6 (2015): 531–43. http://dx.doi.org/10.1590/0004-282x20150042.

Full text
Abstract:
Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifes
APA, Harvard, Vancouver, ISO, and other styles
2

Rodrigues, Luiz Oswaldo Carneiro, Pollyanna Barros Batista, Eny Maria Goloni-Bertollo, et al. "Neurofibromatoses: part 1 ? diagnosis and differential diagnosis." Arquivos de Neuro-Psiquiatria 72, no. 3 (2014): 241–50. http://dx.doi.org/10.1590/0004-282x20130241.

Full text
Abstract:
Neurofibromatoses (NF) are a group of genetic multiple tumor growing predisposition diseases: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH), which have in common the neural origin of tumors and cutaneous signs. They affect nearly 80 thousand of Brazilians. In recent years, the increased scientific knowledge on NF has allowed better clinical management and reduced complication morbidity, resulting in higher quality of life for NF patients. In most cases, neurology, psychiatry, dermatology, clinical geneticists, oncology and internal medicine specialist
APA, Harvard, Vancouver, ISO, and other styles
3

Mulvihill, John J. "Neurofibromatosis 1 (Recklinghausen Disease) and Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis)." Annals of Internal Medicine 113, no. 1 (1990): 39. http://dx.doi.org/10.7326/0003-4819-113-1-39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pollack, Ian F., and Jonn J. Mulvihill. "Neurofibromatosis 1 and 2." Brain Pathology 7, no. 2 (1997): 823–36. http://dx.doi.org/10.1111/j.1750-3639.1997.tb01067.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sanchez, Lauren D., Ashley Bui, and Laura J. Klesse. "Targeted Therapies for the Neurofibromatoses." Cancers 13, no. 23 (2021): 6032. http://dx.doi.org/10.3390/cancers13236032.

Full text
Abstract:
Over the past several years, management of the tumors associated with the neurofibromatoses has been recognized to often require approaches that are distinct from their spontaneous counterparts. Focus has shifted to therapy aimed at minimizing symptoms given the risks of persistent, multiple tumors and new tumor growth. In this review, we will highlight the translation of preclinical data to therapeutic trials for patients with neurofibromatosis, particularly neurofibromatosis type 1 and neurofibromatosis type 2. Successful inhibition of MEK for patients with neurofibromatosis type 1 and progr
APA, Harvard, Vancouver, ISO, and other styles
6

Reynolds, RM, GGP Browning, I. Nawroz, and IW Campbell. "Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1." Lancet 361, no. 9368 (2003): 1552–54. http://dx.doi.org/10.1016/s0140-6736(03)13166-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yehouenou Tessi, Romeo Thierry, Chaimae Lahlou, Soufiane Rostoum, Siham El Haddad, Nazik Allali, and Latifa Chat. "A supraclavicular mass with skin macules «café-au-lait»: Neurofibromatosis 1." International Journal of Case Reports and Images 14, no. 2 (2023): 57–62. http://dx.doi.org/10.5348/101411z01rt2023cr.

Full text
Abstract:
Neurofibromatosis type 1 is a genetic disorder representing one of the most common forms of Von Recklinghausen’s disease. The neurofibromatoses are a group of heterogeneous, yet distinct, autosomal-dominant inherited neurogenetic disorders that include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. It is characterized by a large clinical polymorphism with the development of «café-au-lait» skin spots, benign tumors affecting the skin, peripheral nerves, optic pathway, and can involve the brain, bones, and vessels. We report the case of an 8-year-old child w
APA, Harvard, Vancouver, ISO, and other styles
8

Flexon, Phillip B., Joseph B. Nadol, William W. Montgomery, Harold F. Schuknecht, and Robert L. Martuza. "Bilateral Acoustic Neurofibromatosis (Neurofibromatosis 2): A Disorder Distinct from Von Recklinghausen's Neurofibromatosis (Neurofibromatosis 1)." Annals of Otology, Rhinology & Laryngology 100, no. 10 (1991): 830–34. http://dx.doi.org/10.1177/000348949110001008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Borofsky, S., and L. M. Levy. "Neurofibromatosis: Types 1 and 2." American Journal of Neuroradiology 34, no. 12 (2013): 2250–51. http://dx.doi.org/10.3174/ajnr.a3534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yohay, Kaleb. "Neurofibromatosis Types 1 and 2." Neurologist 12, no. 2 (2006): 86–93. http://dx.doi.org/10.1097/01.nrl.0000195830.22432.a5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Neurofibromatosis 1 And 2"

1

Ardern-Holmes, Simone. "Neurofibromatosis Type 1 and Type 2 Associated Tumours: Current trends in Diagnosis and Management with a focus on Novel Medical Therapies." Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/17936.

Full text
Abstract:
Neurofibromatosis type 1 (NF1) and Neurofibromatosis type 2 (NF2) are distinct single gene disorders, which share a predisposition to formation of benign nervous system tumours due to loss of tumour suppressor function. Since identification of the genes encoding NF1 and NF2 in the early 1990s, significant progress has been made in understanding the biological processes and molecular pathways underlying tumour formation. As a result, identifying safe and effective medical approaches to treating NF1 and NF2-associated tumours has become a focus of clinical research and patient care in recent ye
APA, Harvard, Vancouver, ISO, and other styles
2

Mantripragada, Kiran K. "Microarray-Based Comparative Genomic Hybridization in Neurofibromatoses and DiGeorge Syndrome." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5743.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shilyansky, Carrie. "Increased inhibition within frontal corticostriatal networks underlies working memory impairments in a mouse model of neurofibromatosis type 1." Diss., Restricted to subscribing institutions, 2009. http://proquest.umi.com/pqdweb?did=1905652701&sid=1&Fmt=2&clientId=48051&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brault, Estelle. "Etude structurale et fonctionnelle de la schwannomine, produit du gene suppresseur de tumeur impliquee dans la neurofibromatose de type 2." Paris 5, 2001. http://www.theses.fr/2001PA05N081.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Roehl, Angelika [Verfasser]. "Analysen zum Entstehungsmechanismus von Typ-2 NF1 Deletionen bei Patienten mit Neurofibromatose Typ 1 / Angelika Roehl." Ulm : Universität Ulm. Medizinische Fakultät, 2012. http://d-nb.info/1027762263/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fagelson, Marc A. "Tinnitus in Neurofibromatosis 2." Digital Commons @ East Tennessee State University, 2013. https://dc.etsu.edu/etsu-works/1649.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ferner, Rosalie Elaine. "Intellect in neurofibromatosis 1." Thesis, University of Newcastle Upon Tyne, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.283079.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Goucha, Tomás Barato. "Genetic Diagnosis of Neurofibromatosis Type 2." Master's thesis, Instituto de Ciências Biomédicas Abel Salazar, 2009. http://hdl.handle.net/10216/53388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Antinheimo, Juha-Pekka. "Meningiomas and schwannomas in neurofibromatosis 2." Helsinki : University of Helsinki, 1999. http://ethesis.helsinki.fi/julkaisut/laa/haart/vk/antinheimo/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Goucha, Tomás Barato. "Genetic Diagnosis of Neurofibromatosis Type 2." Dissertação, Instituto de Ciências Biomédicas Abel Salazar, 2009. http://hdl.handle.net/10216/53388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Neurofibromatosis 1 And 2"

1

1943-, Mulvihill John J., Parry Dilys M, and National Institutes of Health (U.S.), eds. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (Bilateral acoustic neurofibromatosis): An update. National Institutes of Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tadini, Gianluca, Eric Legius, and Hilde Brems, eds. Multidisciplinary Approach to Neurofibromatosis Type 1. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-92450-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Martuza, Robert L. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). National Institute of Neurological and Communicative Disorders and Stroke, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Upadhyaya, Meena, and David N. Cooper, eds. Neurofibromatosis Type 1. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-32864-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

North, Kathryn. Neurofibromatosis type 1 in childhood. Mac Keith Press, for the International Child Neurology Association, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Watson, Carolyn Joyce. Molecular genetic investigations in Type 2 neurofibromatosis. University of Manchester, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dr, Cooper David N., and Upadhyaya M, eds. Neurofibromatosis type 1: From genotype to phenotype. Bios Scientific, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jeske, Nelissen, ed. 2+ 1. De Fontein, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cai, Hongzhong. 1/2 wang zi: 1/2 prince. Dong li chu ban she you xian gong si, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cai, Hongzhong. 1/2 wang zi: 1/2 prince. Dong li chu ban she you xian gong si, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Neurofibromatosis 1 And 2"

1

Tihan, Tarik. "Neurofibromatosis 2." In Atlas of Pediatric Brain Tumors. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-1062-2_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Harold. "Neurofibromatosis 2." In Atlas of Genetic Diagnosis and Counseling. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-2401-1_179.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Peltonen, Sirkku, Vesa Aaltonen, and Juha Peltonen. "Neurofibromatosis-1." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_4036-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Harold. "Neurofibromatosis 1." In Atlas of Genetic Diagnosis and Counseling. Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6430-3_178-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gorelyshev, Sergey, Endzhe Valiakhmetova, and Igor Pronin. "Neurofibromatosis 2." In Textbook of Pediatric Neurosurgery. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-31512-6_151-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chen, Harold. "Neurofibromatosis 2." In Atlas of Genetic Diagnosis and Counseling. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-6430-3_179-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Armstrong, Carol L. "Neurofibromatosis Type 1 (NF1)." In Encyclopedia of Clinical Neuropsychology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56782-2_133-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Canas, Angela, and Natalie Escalante. "Neurofibromatosis Type 1 and Neurofibromatosis Type 2-Related Schwannomatosis." In Understanding and Managing Neurodevelopmental Disorders in Children and Adolescents. Routledge, 2025. https://doi.org/10.4324/9781032703923-24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Huson, Susan M. "Neurofibromatosis (NF) types 1 and 2." In Genetic Predisposition to Cancer. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-4501-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Eoli, Marica. "Neurofibromatosis Type 1 and Type 2." In Prognosis of Neurological Diseases. Springer Milan, 2015. http://dx.doi.org/10.1007/978-88-470-5755-5_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Neurofibromatosis 1 And 2"

1

Bagnoli, D. L., J. W. Leedy, and T. Wada. "Embrittlement of 1 Cr-1/2 Mo and 1 1/4 Cr-1/2 Mo Alloys after Long Time Service." In CORROSION 1988. NACE International, 1988. https://doi.org/10.5006/c1988-88160.

Full text
Abstract:
Abstract During the past few years there has been increasing evidence of material changes occurring in aging Refinery and Petrochemical equipment. An example is the embrittlement of low chromium-molybdenum steels. This embrittlement can be manifested either by loss of creep rupture strength and ductility in heat affected zones (HAZ) of welds or loss of base metal, room temperature CVN toughness. Recently, there have been cases where one or both types of materials degradation have been reported. A case is cited here where both forms of degradation were found. It was determined that initial serv
APA, Harvard, Vancouver, ISO, and other styles
2

Leino, Viljami, Alexei Bazavov, Nora Brambilla, et al. "Strong coupling in (2+1+1)-flavor QCD." In The 41st International Symposium on Lattice Field Theory. Sissa Medialab, 2025. https://doi.org/10.22323/1.466.0298.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Coyne, Geraldine O'Sullivan, Andrea Gross, Eva Dombi, et al. "Abstract PR07: Phase II Trial of the MEK 1/2 inhibitor selumetinib (AZD6344, ARRY-142886 hydrogen sulphate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN)." In Abstracts: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; October 26-30, 2019; Boston, MA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1535-7163.targ-19-pr07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Caesario, D., J. E. Casino, and S. Jesmajian. "Atypical Pulmonary Manifestations of Neurofibromatosis Type 1." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Soldano, Lucia, Carmela De Meco, Irene Rutigliano, et al. "P295 Optical pathway glioma and neurofibromatosis type 1." In 8th Europaediatrics Congress jointly held with, The 13th National Congress of Romanian Pediatrics Society, 7–10 June 2017, Palace of Parliament, Romania, Paediatrics building bridges across Europe. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313273.383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ellberg, C., W. C. Mcguire, and J. Joshua. "A Case of Spontaneous Pneumothorax in Neurofibromatosis-1." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5822.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fernández, Paloma, Pablo Lara, and María Barberá. "Estudio de Neurofibromatosis tipo 1 en paciente adulto." In 30 Congreso Nacional de Medicina General y de Familia. Grupo Pacífico, 2024. http://dx.doi.org/10.48158/semg24-365.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Plitt, Aaron R., James R. Dornhoffer, Maria Peris-Celda, et al. "Multidisciplinary Neurofibromatosis Type 2 Clinic: The Mayo Clinic Experience." In 32nd Annual Meeting North American Skull Base Society. Georg Thieme Verlag KG, 2023. http://dx.doi.org/10.1055/s-0043-1762130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Molis, Amy, Bruce Greenberg, and Andres Sosa. "Spontaneous Hemothorax In A Patient With Neurofibromatosis Type 1." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5959.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brar, H., M. A. Saad, A. Ng, and R. M. Abdallah. "Pulmonary Manifestations of a Rare Disease, Neurofibromatosis Type-1." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5795.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Neurofibromatosis 1 And 2"

1

Viskochil, David. A Phase 2 Trial on the Effect of Low-Dose versus High-Dose Vitamin D Supplementation on Bone Mass in Adults with Neurofibromatosis 1 (NF1). Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada612069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Slattery, William H., and III. Neurofibromatosis Type 2 (NF2) Natural History Consortium. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada434786.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Slattery, William H., and III. Neurofibromatosis Type 2 (NF2) Natural History Consortium. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada414115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Slattery, William. Neurofibromatosis Type 2 (NF2) Natural History Consortium. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada425862.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bernards, Andre. Studies of Neurofibromatosis-1 Modifier Genes. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada437252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kurtz, Andreas. Mitochondria Polymorphism in Neurofibromatosis Type 1. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada400622.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bernards, Andre. Studies of Neurofibromatosis-1 Modifier Genes. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada428418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kurtz, Andreas. Mitochondria Polymorphism in Neurofibromatosis Type 1. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada411354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kurtz, Andreas C. Mitochondria Polymorphism in Neurofibromatosis Type 1. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada420949.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sánchez Legaza, Elena. Neurofibromatosis tipo 2 manifestada como schwannoma vestibular bilateral. Siicsalud.com, 2017. http://dx.doi.org/10.21840/siic/154613.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Neurofibromatosis 1 And 2' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography